INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F60m ago
Robinhood Chain60m ago

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
BE
Bertels Mark E.EVP - Risk Management Services
CRVLCORVEL CORP
Option exercise
M$42K
1,050 sh
Apr 22, 2026Apr 23, 2026
Page 912 of 1737
← PrevNext →
traded Apr 22, 2026
+1d
SEC Form 4

Evidence

13
LM
Larson MichelleChief Merchandising Officer
ACIAlbertsons Companies, Inc.
Tax withholding
F—
16.7K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
85 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
SD
Schmitz Ronald D.Director
NONENONEKKR Private Equity Conglomerate LLC
Grant or award
A—
338 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
EH
Engstrom Jonas HakanChief Operating Officer
PSNYPolestar Automotive Holding UK PLC
Grant or award
A—
231 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
BS
Barry Corie SDirector
DPZDOMINOS PIZZA INC
Grant or award
A—
515 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
NA
Newhouse Michael ADirector
CHTRCHARTER COMMUNICATIONS, INC. /MO/
Grant or award
A—
918 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
BR
Backus RobertEVP Retail Operations East
ACIAlbertsons Companies, Inc.
Tax withholding
F—
7,145 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Tax withholding
F—
2,274 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Tax withholding
F—
2,988 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
LB
Larson Robert BruceSVP & Chief Accounting Officer
ACIAlbertsons Companies, Inc.
Tax withholding
F—
7,443 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
DF
Dicken Scott FraserChief Commercial Officer
PSNYPolestar Automotive Holding UK PLC
Grant or award
A—
92 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Option exercise
M—
9,322 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

13
KM
Kumbier MichelleDirector
TDYTELEDYNE TECHNOLOGIES INC
Grant or award
A—
319 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
43 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

13
LE
Lopez Patricia EDirector
DPZDOMINOS PIZZA INC
Grant or award
A—
515 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

13
KM
Krishnan MeenaDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
497.7K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
105.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DF
Dicken Scott FraserChief Commercial Officer
PSNYPolestar Automotive Holding UK PLC
Option exercise
M—
1,764 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
MS
Morris SusanDirector, Chief Executive Officer
ACIAlbertsons Companies, Inc.
Tax withholding
F—
17.5K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
69.4K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GW
Grossman WilliamDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
66.7K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
300.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GB
Gunn L. BurwellDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
20.2K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
SG
Simmonds Sidney GDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
HJ
Hord Michael JosephChief Financial Officer
COOKTraeger, Inc.
Tax withholding
F$7,086
163 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Option exercise
M—
5,375 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
40.6K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
CA
Clements Carol AnnChief Digital & Tech Officer
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
160.3K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
5,250 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
244.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
188.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
151.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
MS
Mccollam SharonPresident & CFO
ACIAlbertsons Companies, Inc.
Tax withholding
F—
11.7K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
SJ
St George Martin JPresident
JBLUJETBLUE AIRWAYS CORP
Option exercise
M—
46.9K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
346.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence